Description
Myelinoligodendrocyteglycoprotein(35-55)isapeptideusedtoinduceexperimentalautoimmuneencephalitis(EAE)viaimmunization;itisanantigenthatinducesanimmuneresponseagainstmyelindesignedtomimicconditionsofmultiplesclerosis.
Myelinoligodendrocyteglycoprotein(35-55)isapeptideusedtoinduceexperimentalautoimmuneencephalitis(EAE)viaimmunization;itisanantigenthatinducesanimmuneresponseagainstmyelindesignedtomimicconditionsofmultiplesclerosis.
| CasNo. | 163913-87-9 |
|---|---|
| Purity | ≥98% |
| Formula | C118H177N35O29S |
| FormulaWt. | 2582.0 |
| Synonym | MOG(35-55) |
| Appearance | Whitetooffwhitepowder |
| StoreTemp | -20°C |
|---|---|
| ShipTemp | Ambient |
| InfoSheet | M9645InfoSheetPDF |
|---|
ZhuD,LiuM,YangY,etal.GinsenosideRdamelioratesexperimentalautoimmuneencephalomyelitisinC57BL/6mice.JNeurosciRes.2014May2.[Epubaheadofprint].PMID:24798871.
SosaRA,MurpheyC,JiN,etal.Thekineticsofmyelinantigenuptakebymyeloidcellsinthecentralnervoussystemduringexperimentalautoimmuneencephalomyelitis.JImmunol.2013Dec15;191(12):5848-57.PMID:24227784.